McMullen most recently served as director at the Food and Drug Administration’s Office of Neurological and Physical Medicine Devices, which is responsible for the total lifecycle review of devices such as Neuralink’s brain implant. The move places a top government official inside Musk’s orbit after the billionaire led a government cost-cutting enterprise earlier this year that forced out regulators overseeing Neuralink and other medical device companies. The FDA ended up asking some of those scientists to return.
Read More Startups-Tech-Economic Times